1. Evidence quality assessment, case‐control studies.
Studya | Selection | Comparability of cases and controls | Exposure | Evidence qualityb | |||||
Case definition | Cases representative | Control selection | Control definition | Ascertainment method | Same ascertainment both groups | Nonresponse rate | |||
La Vecchia 1999 | ✸ | ✸ | ‐ | ‐ | ✸ | ‐ | ✸ | ✸ | Very low |
Mallmin 1994 | ✸ | ✸ | ✸ | ✸ | ✸ | ‐ | ✸ | ✸ | Low |
Meier 2010 | ✸ | ✸ | ✸ | ‐ | ✸✸ | ✸ | ✸ | ✸ | Moderate |
Memon 2011 | ✸ | ✸ | ✸ | ✸ | ✸✸ | ✸ | ✸ | ✸ | High |
Michaelsson 1999 | ✸ | ✸ | ✸ | ‐ | ✸✸ | ‐ | ✸ | ✸ | Low |
O'Neill 1996 | ✸ | ✸ | ✸ | ‐ | ✸✸ | ‐ | ✸ | ‐ | Low |
Vestergaard 2006c | ✸ | ✸ | ✸ | ‐ | ✸✸ | ✸ | ✸ | ✸ | Moderate |
aNewcastle‐Ottawa Quality Assessment Scale (Appendix 3): 1 star (✸) for meeting each criterion, except comparability (design or analysis) can have 2 stars. For comparability in this review: 1 star if controlled for age; 2 stars if also controlled for other important variables, e.g., exercise, body mass index, use of hormone replacement therapy or other relevant drugs bModerate quality evidence: met criteria for selection (4 items), comparability (1 star; upgraded for 2 stars), and ascertainment method; downgrading due to design limitation or lack of information in report cVestergaard 2006 includes 3 reports: OC use (2006), OC use among young women (2008a); use of DMPA or hormonal IUD (2008b)